Mike Karim is the CEO of Oxford Endovascular, a spin–off from the University of Oxford, which is developing a technology to prevent brain hemorrhage or ruptures of blood vessels in thebrain – otherwise fatal to 1/3 of the people affected by this condition.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.